Alex Mas Monteys

2.5k total citations
18 papers, 1.7k citations indexed

About

Alex Mas Monteys is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Alex Mas Monteys has authored 18 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 8 papers in Cellular and Molecular Neuroscience and 3 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Alex Mas Monteys's work include Genetic Neurodegenerative Diseases (8 papers), RNA Interference and Gene Delivery (6 papers) and CRISPR and Genetic Engineering (4 papers). Alex Mas Monteys is often cited by papers focused on Genetic Neurodegenerative Diseases (8 papers), RNA Interference and Gene Delivery (6 papers) and CRISPR and Genetic Engineering (4 papers). Alex Mas Monteys collaborates with scholars based in United States, France and Russia. Alex Mas Monteys's co-authors include Beverly L. Davidson, Ryan L. Boudreau, Luis Tecedor, Megan S. Keiser, Ryan M. Spengler, Jodi L. McBride, Yi Xing, Ji Wan, Brian L. Gilmore and Patrick D. Staber and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Alex Mas Monteys

17 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alex Mas Monteys United States 14 1.4k 460 412 270 125 18 1.7k
Patrick D. Staber United States 10 1.2k 0.9× 485 1.1× 157 0.4× 554 2.1× 148 1.2× 11 1.5k
Yonatan Stelzer Israel 18 1.9k 1.4× 128 0.3× 203 0.5× 573 2.1× 131 1.0× 26 2.2k
Soonmoon Yoo United States 28 1.7k 1.2× 712 1.5× 347 0.8× 96 0.4× 126 1.0× 37 2.3k
Melvin M. Evers Netherlands 22 1.3k 0.9× 671 1.5× 95 0.2× 216 0.8× 264 2.1× 39 1.6k
Davide Gabellini Italy 22 1.6k 1.2× 160 0.3× 337 0.8× 243 0.9× 27 0.2× 46 1.8k
Iksoo Jeon South Korea 18 828 0.6× 368 0.8× 98 0.2× 164 0.6× 101 0.8× 53 1.2k
Tsuyoshi Udagawa Japan 22 1.3k 0.9× 111 0.2× 139 0.3× 192 0.7× 214 1.7× 30 1.6k
Seyed Mehdi Jafarnejad Canada 24 1.2k 0.8× 128 0.3× 351 0.9× 170 0.6× 28 0.2× 50 1.6k
Francesco Lotti United States 21 1.9k 1.4× 211 0.5× 68 0.2× 204 0.8× 202 1.6× 36 2.3k
Tomonori Nakamura Japan 27 2.6k 1.9× 255 0.6× 124 0.3× 677 2.5× 108 0.9× 62 3.2k

Countries citing papers authored by Alex Mas Monteys

Since Specialization
Citations

This map shows the geographic impact of Alex Mas Monteys's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alex Mas Monteys with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alex Mas Monteys more than expected).

Fields of papers citing papers by Alex Mas Monteys

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alex Mas Monteys. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alex Mas Monteys. The network helps show where Alex Mas Monteys may publish in the future.

Co-authorship network of co-authors of Alex Mas Monteys

This figure shows the co-authorship network connecting the top 25 collaborators of Alex Mas Monteys. A scholar is included among the top collaborators of Alex Mas Monteys based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alex Mas Monteys. Alex Mas Monteys is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Amado, Defne A., Ashley B. Robbins, Yonghong Chen, et al.. (2025). Author Correction: AAV-based delivery of RNAi targeting ataxin-2 improves survival and pathology in TDP-43 mice. Nature Communications. 16(1). 9356–9356.
2.
Amado, Defne A., Ashley B. Robbins, Yonghong Chen, et al.. (2025). AAV-based delivery of RNAi targeting ataxin-2 improves survival and pathology in TDP-43 mice. Nature Communications. 16(1). 5334–5334. 1 indexed citations
3.
Li, Fang, Qian Liu, Alex Mas Monteys, et al.. (2022). DeepRepeat: direct quantification of short tandem repeats on signal data from nanopore sequencing. Genome biology. 23(1). 108–108. 28 indexed citations
4.
Li, Fang, Alex Mas Monteys, Alexandra Dürr, et al.. (2022). Haplotyping SNPs for allele-specific gene editing of the expanded huntingtin allele using long-read sequencing. Human Genetics and Genomics Advances. 4(1). 100146–100146. 10 indexed citations
5.
Monteys, Alex Mas, Paul T. Ranum, Luis Tecedor, et al.. (2021). Regulated control of gene therapies by drug-induced splicing. Nature. 596(7871). 291–295. 83 indexed citations
6.
Monteys, Alex Mas, et al.. (2017). CRISPR/Cas9 Editing of the Mutant Huntingtin Allele In Vitro and In Vivo. Molecular Therapy. 25(1). 12–23. 230 indexed citations
7.
Fishbein, Ilia, Ivan S. Alferiev, Jessica Foster, et al.. (2017). Stent-based delivery of adeno-associated viral vectors with sustained vascular transduction and iNOS-mediated inhibition of in-stent restenosis. Gene Therapy. 24(11). 717–726. 18 indexed citations
8.
Ochaba, Joseph, Alex Mas Monteys, Jacqueline G. O’Rourke, et al.. (2016). PIAS1 Regulates Mutant Huntingtin Accumulation and Huntington’s Disease-Associated Phenotypes In Vivo. Neuron. 90(3). 507–520. 62 indexed citations
9.
Monteys, Alex Mas, Matthew Wilson, Ryan L. Boudreau, Ryan M. Spengler, & Beverly L. Davidson. (2015). Artificial miRNAs Targeting Mutant Huntingtin Show Preferential Silencing In Vitro and In Vivo. Molecular Therapy — Nucleic Acids. 4. e234–e234. 28 indexed citations
10.
Monteys, Alex Mas, et al.. (2014). Single nucleotide seed modification restores in vivo tolerability of a toxic artificial miRNA sequence in the mouse brain. Nucleic Acids Research. 42(21). 13315–13327. 18 indexed citations
11.
Lee, John H., Luis Tecedor, Yong Hong Chen, et al.. (2014). Reinstating Aberrant mTORC1 Activity in Huntington’s Disease Mice Improves Disease Phenotypes. Neuron. 85(2). 303–315. 122 indexed citations
12.
Conforti, Paola, Alex Mas Monteys, Chiara Zuccato, et al.. (2012). In vivo delivery of DN:REST improves transcriptional changes of REST-regulated genes in HD mice. Gene Therapy. 20(6). 678–685. 27 indexed citations
13.
Ebert, Scott M., Alex Mas Monteys, Daniel K. Fox, et al.. (2010). The Transcription Factor ATF4 Promotes Skeletal Myofiber Atrophy during Fasting. Molecular Endocrinology. 24(4). 790–799. 106 indexed citations
14.
Monteys, Alex Mas, Ryan M. Spengler, Ji Wan, et al.. (2010). Structure and activity of putative intronic miRNA promoters. RNA. 16(3). 495–505. 295 indexed citations
15.
Muñoz, Sergio, Sylvie Franckhauser, Ivet Elias, et al.. (2010). Chronically increased glucose uptake by adipose tissue leads to lactate production and improved insulin sensitivity rather than obesity in the mouse. Diabetologia. 53(11). 2417–2430. 33 indexed citations
16.
Ebert, Scott M., Alex Mas Monteys, Daniel K. Fox, et al.. (2010). The Transcription Factor ATF4 Promotes Skeletal Myofiber Atrophy during Fasting. The Journal of Clinical Endocrinology & Metabolism. 95(3). 1478–1478. 2 indexed citations
17.
Boudreau, Ryan L., Alex Mas Monteys, & Beverly L. Davidson. (2008). Minimizing variables among hairpin-based RNAi vectors reveals the potency of shRNAs. RNA. 14(9). 1834–1844. 117 indexed citations
18.
McBride, Jodi L., Ryan L. Boudreau, Scott Q. Harper, et al.. (2008). Artificial miRNAs mitigate shRNA-mediated toxicity in the brain: Implications for the therapeutic development of RNAi. Proceedings of the National Academy of Sciences. 105(15). 5868–5873. 472 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Patrick D. Staber Breakdown of academic impact, for papers by Yonatan Stelzer Breakdown of academic impact, for papers by Soonmoon Yoo Breakdown of academic impact, for papers by Melvin M. Evers Breakdown of academic impact, for papers by Davide Gabellini Breakdown of academic impact, for papers by Iksoo Jeon Breakdown of academic impact, for papers by Tsuyoshi Udagawa Breakdown of academic impact, for papers by Seyed Mehdi Jafarnejad Breakdown of academic impact, for papers by Francesco Lotti Breakdown of academic impact, for papers by Tomonori Nakamura
Rankless by CCL
2026